Cargando…

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study

BACKGROUND: Assessment of muscle quantity by sonographic muscle indices could help identify patients at risk for fatal outcome during coronavirus disease‐2019 (COVID‐19). The aim of this study was to explore sonographic muscle indices as predictors of COVID‐19 outcome and to test the feasibility of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kremer, Wolfgang M., Labenz, Christian, Kuchen, Robert, Sagoschen, Ingo, Bodenstein, Marc, Schreiner, Oliver, Wörns, Marcus A., Sivanathan, Visvakanth, Weinmann, Arndt, Galle, Peter R., Sprinzl, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles: Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818698/ https://www.ncbi.nlm.nih.gov/pubmed/34881516 http://dx.doi.org/10.1002/jcsm.12862

Ejemplares similares

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
por: Labenz, Christian, et al.
Publicado: (2020)

Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19
por: Hollerbach, Anne, et al.
Publicado: (2021)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study
por: Schmitt, Volker H., et al.
Publicado: (2023)

Obesity and Its Impact on Adverse In-Hospital Outcomes in Hospitalized Patients With COVID-19
por: Keller, Karsten, et al.
Publicado: (2022)

No Evidence for Classic Thrombotic Microangiopathy in COVID-19
por: Falter, Tanja, et al.
Publicado: (2021)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
por: Nagel, Michael, et al.
Publicado: (2023)

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program
por: Moehler, Markus, et al.
Publicado: (2019)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
por: Sprinzl, Martin F., et al.
Publicado: (2021)

Evaluation of novel LCI CAD EYE system for real time detection of colon polyps
por: Neumann, Helmut, et al.
Publicado: (2021)

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

Evaluation of a novel colonoscope offering flexibility adjuster – a retrospective observational study
por: Gerges, Christian, et al.
Publicado: (2021)

(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
por: Labenz, Christian, et al.
Publicado: (2020)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
por: Nagel, Michael, et al.
Publicado: (2020)

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Development and evaluation of a virtual reality driving test for patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
por: Huber, Yvonne, et al.
Publicado: (2018)

Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
por: Pitton, Michael B., et al.
Publicado: (2014)

Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas
por: Castven, Darko, et al.
Publicado: (2017)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
por: Nagel, Michael, et al.
Publicado: (2022)

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
por: Nagel, Michael, et al.
Publicado: (2022)

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial
por: Kloeckner, Roman, et al.
Publicado: (2014)

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
por: Steinebrunner, Niels, et al.
Publicado: (2015)

Sonographic landmarks in hamstring muscles
por: Balius, Ramon, et al.
Publicado: (2019)

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
por: Weinmann, Arndt, et al.
Publicado: (2015)

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report
por: Knapstein, Johanna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6q2m6gem8jdqhgs92u1i6hf3en